CME Education on The Hill

  • by: |
  • 09/23/2008
CMPI and the Healthcare Communications Coalition of America held a Capitol Hill briefing on continuing medical education today.   It was likely the first time that people who actually provide CME (or serve as partipants and attendants) presented both the facts and their viewpoint in Washington. 

We made no bones about the fact that the briefing would make the case for CME and thanks to our panelists, we did not fail in this task.   George Lundberg, the Editor in Chief of Medscape, made the point that most doctors like CME because they learn things from it that allow them to be better doctors, a theme restated by other participants. 

Moreover,  it became clear that the charges of bias-because-of-commercialism were being leveled by interests who themselves are mired in commercialism and stand to gain from and elimination of the commercial provision of CME.   Further,  the assaults on industry support of CME has discouraged investment according those in the trenches (Marissa Seligman Chief of Clinical Regulatory Affairs for Pri-Med, the largest commercial provider of CME for primary care physicians,  Jack Lewin, president of the American College of Cardiology).  Also discussed are the risk of undermining primary care and underserved populations.   Data was presented by Dr. Leonard Bielory, Tom Sullivan of Rockpointe, and Jeff Drezner, CEO of Clinical Care Options in support of the claim that CME does improve clinical practice.  Dr. Lundberg referenced a JAMA study showing that online CME is  highly effective compared to CME workshops.   And more data is widely available in medical journals underscoring this point. 

CME should be part of an overall approach to making medicine more patient-centered, increasing access to health care in medically underserved communities and improving health outcomes.  None of this achievable by banning or discouraging industry support for CME.  On the contrary we need more CME, not less. 

That was (and is) our message. 

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog